<br />
<b>Warning</b>:  Attempt to read property "ID" on null in <b>/home/vitapharmaconsulting/www/en/wp-content/themes/bones/library/bones.php</b> on line <b>296</b><br />
<br />
<b>Warning</b>:  Attempt to read property "ID" on null in <b>/home/vitapharmaconsulting/www/en/wp-content/themes/bones/library/bones.php</b> on line <b>296</b><br />
<?xml version="1.0"?>
<oembed><version>1.0</version><provider_name>Vita</provider_name><provider_url>https://www.vitapharmaconsulting.com/en</provider_url><title>INFARMED - Economic Evaluation by INFARMED - Vita</title><type>rich</type><width>600</width><height>338</height><html>&lt;blockquote class="wp-embedded-content" data-secret="Y1gYAIxHfo"&gt;&lt;a href="https://www.vitapharmaconsulting.com/en/news/2019/12/18/infarmed-economic-evaluation-by-infarmed/"&gt;INFARMED &#x2013; Economic Evaluation by INFARMED&lt;/a&gt;&lt;/blockquote&gt;&lt;iframe sandbox="allow-scripts" security="restricted" src="https://www.vitapharmaconsulting.com/en/news/2019/12/18/infarmed-economic-evaluation-by-infarmed/embed/#?secret=Y1gYAIxHfo" width="600" height="338" title="&#x201C;INFARMED &#x2013; Economic Evaluation by INFARMED&#x201D; &#x2014; Vita" data-secret="Y1gYAIxHfo" frameborder="0" marginwidth="0" marginheight="0" scrolling="no" class="wp-embedded-content"&gt;&lt;/iframe&gt;&lt;script&gt;
/*! This file is auto-generated */
!function(d,l){"use strict";l.querySelector&amp;&amp;d.addEventListener&amp;&amp;"undefined"!=typeof URL&amp;&amp;(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&amp;&amp;!/[^a-zA-Z0-9]/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret="'+t.secret+'"]'),o=l.querySelectorAll('blockquote[data-secret="'+t.secret+'"]'),c=new RegExp("^https?:$","i"),i=0;i&lt;o.length;i++)o[i].style.display="none";for(i=0;i&lt;a.length;i++)s=a[i],e.source===s.contentWindow&amp;&amp;(s.removeAttribute("style"),"height"===t.message?(1e3&lt;(r=parseInt(t.value,10))?r=1e3:~~r&lt;200&amp;&amp;(r=200),s.height=r):"link"===t.message&amp;&amp;(r=new URL(s.getAttribute("src")),n=new URL(t.value),c.test(n.protocol))&amp;&amp;n.host===r.host&amp;&amp;l.activeElement===s&amp;&amp;(d.top.location.href=t.value))}},d.addEventListener("message",d.wp.receiveEmbedMessage,!1),l.addEventListener("DOMContentLoaded",function(){for(var e,t,s=l.querySelectorAll("iframe.wp-embedded-content"),r=0;r&lt;s.length;r++)(t=(e=s[r]).getAttribute("data-secret"))||(t=Math.random().toString(36).substring(2,12),e.src+="#?secret="+t,e.setAttribute("data-secret",t)),e.contentWindow.postMessage({message:"ready",secret:t},"*")},!1)))}(window,document);
//# sourceURL=https://www.vitapharmaconsulting.com/en/wp-includes/js/wp-embed.min.js
&lt;/script&gt;
</html><thumbnail_url>https://www.vitapharmaconsulting.com/en/wp-content/uploads/2022/04/IMAGEM-116.png</thumbnail_url><thumbnail_width>1920</thumbnail_width><thumbnail_height>1080</thumbnail_height><description>With two publications on December 16, Infarmed informs the public about measures taken in support of the new Portaria published by the Agency in October of this year. The normative in question is n&#xB0; 391/2019. INFARMED has demonstrated to be integrated with the economic evaluation system made by EUnetHA at european level and SiNATS at... Leia mais &raquo;</description></oembed>
